Cyclooxygenase 2 and prostaglandin E2 in the genesis of pregnancy loss in cytomegalovirus infection

Prostaglandins (PGs), regulated by cyclooxygenase (COX) 2, play a significant role in the development of placental disorders in pathological pregnancy. A review of current literature reveals a lack of evidence demonstrating the involvement of PGs in the pathogenesis of early spontaneous miscarriages associated with cytomegalovirus (CMV) infection. The aim of this study was to investigate the levels of COX-2 and PG E2 in peripheral blood and determine their significance in predicting pregnancy loss during exacerbation of CMV infection at 7-8 weeks gestation.
Materials and methods. The study involved 70 patients experiencing an exacerbation of chronic CMV infection at 7-8 weeks of gestation, with 36 patients presenting with a threatened miscarriage (main group) and 34 patients without signs of threatened miscarriage (comparison group). CMV infection was diagnosed based on the presence of M and G class antibodies using enzyme-linked immunosorbent assay (ELISA), as well as CMV DNA detected by polymerase chain reaction. COX-2 levels in mononuclear cell lysates were determined using the "Assay Designs, COX-2" (USA) test systems, and PG E2 concentrations in blood serum were measured using "Cloud-Clone Corp." (USA) kits.
Results. Women with exacerbated CMV infection associated with spontaneous miscarriage at 7-8 weeks of gestation exhibited elevated concentrations of COX-2 (23.0±2.20 ng/mL) and PG E2 (850.10±35.0 pg/mL, p<0.001) compared to pregnant women without threatened miscarriage (12.75±1.35 ng/mL and 42.0±2.80 pg/mL, respectively).
Conclusion. The findings of this study underscore the significant role of elevated COX-2 and PG E2 concentrations in the pathogenesis of pregnancy loss during exacerbation of CMV infection at 7-8 weeks of gestation. The assessment of COX-2 and PG E2 levels should be considered as a predictive measure for the risk of pregnancy loss during exacerbation of CMV infection.

1. Nigametzyanova G.R. [Non-developing pregnancy]. Lecheniye i profilaktika 2017; 2(22):47–55 (in Russian).

2. Petrov Yu.A, Arndt I.G., Bakhtina A.S. [Immunological aspects of pregnancy loss]. Glavnyy vrach yuga Rossii = Glavnyi vrach uga Russia 2021; 1(76):38–41 (in Russian).

3. Tkachenko L.V., Kostenko T.I., Uglova N.D., Shklyar A.L. [Miscarriage]. Vestnik Volgogradskogo gosudarstvennogo meditsinskogo universiteta = Journal of Volgograd state medical university 2015; 1(53):3–9 (in Russian).

4. Batrak N.V., Malyshkina A.I. [Risk factors for habitual incomplete pregnancy]. Vestnik Ivanovskoy meditsinskoy akademii = Bulletin of the Ivanovo state medical academy 2016; 21(4):37–41 (in Russian).

5. Kolesnichenko A.A., Petrov Yu.A. [Chronic endometritis and miscarriage]. Mezhdunarodnyy zhurnal prikladnykh i fundamental'nykh issledovaniy 2019; 10(2):313–317 (in Russian).

6. Chistyakova D.S. [Ovary insufficiency and recurrent miscarriage]. Zhurnal akusherstva i zhenskikh bolezney = Journal of obstetrics and womans diseases 2008; 57(2):100–104 (in Russian).

7. Ishutina N.A., Andriyevskaya I.A. [Prostaglandins and their role at early stages of embryonic development (review)]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2021; 80:129–137 (in Russian). https://doi.org/10.36604/1998-5029-2021-80-129-137

8. Sordelli M.S., Beltrame J.S., Cella M., Gervasi M.G., Perez Martinez S., Burdet J., Zotta E., Franchi A.M., Ribeiro M.L. Interaction between lysophosphatidic acid, prostaglandins and the endocannabinoid system during the window of implantation in the rat uterus. PLoS One 2012; (7)9: e46059. https://doi.org/10.1371/journal.pone.0046059

9. Salleh N. Diverse roles of prostaglandins in blastocyst implantation. Scientific World Journal 2014; 2014:968141. https://doi.org/10.1155/2014/968141

10. Hu S., Li J., Tong M., Li Q., Chen Y., Lu H., Wang Y., Min L. MicroRNA-144-3p may participate in the pathogenesis of preeclampsia by targeting COX-2. Mol. Med. Rep. 2019; 19(6):4655–4662. https://doi.org/10.3892/mmr.2019.10150

11. Ishutina N.A., Andrievskaya I.A., German M.N. [Cyclooxygenase 2 as a marker of early pregnancy loss in cytomegalovirus infection]. Acta Biomedica Scientifica 2020; 5(3):7–12 (in Russian). https://doi.org/10.29413/ABS.2020-5.3.1

12. Mitreski A., Radeka G. Prostacyclin and hormone levels in patients with symptoms of miscarriage and infection. Med. Pregl. 2002; 55(9-10):371–379. https://doi.org/10.2298/mpns0210371m

13. Wang Y., Zhao A., Lin Q. Role of cyclooxygenase-2 signaling pathway dysfunction in unexplained recurrent spontaneous abortion. Chin. Med. J. (Engl). 2010; 123(12):1543–1547.

14. Wang X., Klein R.D. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway. Mol. Carcinog. 2007; 46(11):912–923. https://doi.org/10.1002/mc.20320

15. Sales K.J., Jabbour H.N. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 2003; 126(5):559–567. https://doi.org/10.1530/rep.0.1260559

16. Matsumoto H., Ma W.G., Daikoku T., Zhao X., Paria B.C., Das S.K., Trzaskos J.M., Dey S.K. Cyclooxygenase-2 differentially directs uterine angiogenesis during implantation in mice. J. Biol. Chem. 2002; 277(32):29260–29267. https://doi.org/10.1074/jbc.M203996200

17. Ishutina N.A., Dorofienko N.N., Andievskaya I.A. [Malondialdehyde and tumor necrosis factor alpha at cytomegalovirus infection during pregnancy]. Bûlleten' fiziologii i patologii dyhaniâ = Bulletin Physiology and Pathology of Respiration 2015; 55:78–81 (in Russian).

18. Kyser K.L., Morriss F.H. Jr, Bell E.F., Klein J.M., Dagle J.M. Improving survival of extremely preterm infants born between 22 and 25 weeks of gestation. Obstet. Gynecol. 2012; 119(4):795–800. https://doi.org/10.1097/AOG.0b013e31824b1a03

19. Krivchik G.V. [The diagnosis and prediction of intrauterine infection: current possibilities and prospects]. Akusherstvo i ginekologiya = Obstetrics and gynecology 2008; 2:10–12 (in Russian).

20. Tucker J., McGuire W. Epidemiology of preterm birth. BMJ 2004; 329(7467):675–678. https://doi.org/10.1136/bmj.329.7467.675